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Background: Colorectal cancer (CRC) overall incidence has been decreasing in the last decade. However, there is
evidence of an increasing frequency of early-onset CRC in young individuals in several countries. The aim of this
study is to evaluate the trends of CRC occurrence over 17 years in the municipality of Milan, Italy, focusing on
early-onset CRC.
Population and methods: This retrospective study was performed using the Cancer Registry of the municipality of
Milan, including all cases of CRC diagnosed 1999-2015. Incidence rates were stratiﬁed by age and anatomic
subsite, and trends over time were measured using the estimated annual percentage change. Age-period-cohort
modelling was used to disentangle the diﬀerent eﬀects.
Results: 18,783 cases of CRC were included. CRC incidence rates among individuals aged 50–60 years declined
annually by 3% both in colon and in rectal cancer. Conversely, in adults younger than 50 years, overall CRC
occurrence increased annually by 0.7%, with a diverging trend for colon (+2.6%) and rectal (−5.3%) cancer.
Among individuals aged 60 years and older, CRC incidence rates increased by 1.0% annually up to 2007, and
decrease thereafter by 4% per year, both for colon and rectal cancer. Age-period-cohort models showed a re-
duction of CRC risk for the cohorts born up to 1979, followed by an increase in younger cohorts. In contrast,
rectal cancer among women showed a systematic risk decrease for all birth cohorts.
Conclusions: The study highlights increasing incidence of colon cancer in younger subjects and a decrease in
incidence rates for rectal cancer in females.
1. Introduction
Colorectal cancer (CRC) represents the third most common malig-
nancy in high-income countries where it also ranks as the third leading
cause of cancer deaths, being prominent among non-smokers [1].
Overall, CRC occurrence and mortality have declined drastically after
1990 due to a multiplicity of factors, including increased screening in
the middle-age population [2–4]. The diﬀusion of colonoscopy as a
screening procedure in adults aged 50–75 years reduced the annual
incidence rate of about 4% per year in the United States between 2008
and 2012, in both genders. This eﬀect is mediated by the resection of
pre-malignant lesion i.e. adenomas [5,6]. However, 11% of colon and
18% of rectal cancers are nowadays diagnosed among adults below 50
years (early-onset CRC; EO-CRC). In the United States, CRC incidence
under 50 years of age raised by 1.5% per year in men and 1.6% in
women from 1992 to 2005. More in detail, the average annual increase
was of 2.7% for colon and 3.9% for rectal cancer from 2001 to 2007
[7–9]. Based on current trends, in the United States colon and rectal
cancer incidence rates are expected to increase by 124% for patients
aged 20–34 years, and by 46% for patients ages 35–49 years by 2030
compared with 2010 [10]. Similar trends were also described in Canada
[11], Australia [12] and New Zealand [13]. No recent large population
study reporting on CRC incidence among young individuals is available
in Europe [14,15]. Despite the described increasing incidence trend in
young adults, screening is not routinely recommended in this age group
for individuals without a known hereditary cancer syndrome or family
history [1,16].
The aim of this study is to describe CRC incidence trends and to
examine the age, period and cohort eﬀects in the municipality of Milan
from 1999 to 2015, using data from the population-based Cancer
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Registry, focusing on early-onset CRC.
2. Population and methods
A retrospective cohort study was performed including all new di-
agnosis of colon and rectal cancer occurring, from 1999 to 2015, in the
population of the Milan Municipality (1,300,000 inhabitants). This area
is covered cancer register accredited by IARC that has continuously
collected all new invasive cancers from January 1999. Starting from
2016, the Milan Municipality is part of cancer register of the
Metropolitan area of Milan, included in Cancer Incidence in Five
Continents – XI, covering the entire provinces of Milan for 3,176,180
inhabitants.
For the purpose of this study, CRC was deﬁned using the
International Classiﬁcation of Diseases for Oncology (3rd edition, ICD-
O-3) topography codes C18-C20. Each tumour was also classiﬁed in an
anatomic sub-site, according to the ICD-O-3: proximal colon (C18.0,
C18.2-C18.5), distal colon (C18.6-C18.7), and rectum (C19.9, C20.9).
Extra-nodal lymphomas (ICD-O-3 morphologic codes: 9673/3, 9687/3),
and sarcomas (9120/3, 8936/3, 9140/3, 8890/3) were excluded from
the analysis.
Patient characteristics included gender and age at diagnosis.
Considering 50 years as the lower cut-oﬀ for screening being re-
commended and 65 years as the expected age of retirement, the cohort
was also divided into three age groups:< 50, 50–65, and>65 years.
Available tumour characteristics included ICD-O-3 coded morphology,
histologic grade, and Dukes’ pathological stage at diagnosis [17].
Age speciﬁc CRC incidence rates by gender were computed for the
following age groups:< 45, 45–54, 55–64, 65+ years. To disentangle
the age-period-cohort eﬀects, three separate analyses were carried out.
First, a graphical approach was used: age speciﬁc (< 45, 45–54, 55–64,
65+ years) incidence rates were computed by birth cohort (10-years
intervals from 1915 to 1975) for colon and rectum, and plotted against
the central year of the birth cohort. The points corresponding to the
same age group were joined, to allow an easier reading of the cohort
eﬀect on the ordinate. Secondly, age-speciﬁc incidence trends and
Annual Percentage Change (APC) were estimated using the joinpoint
regression approach [18]. A joinpoint is a time point conjoining two
segments with signiﬁcantly diﬀerent slopes, i.e. incidence trends. This
method allows to estimate and select the simplest model with the best
ﬁtting linear segments, minimizing the sum of the weighted least
squares distances from data points to segments. A maximum of 3
joinpoints was allowed and the ﬁtted models were linear on the natural
logarithm of the rates. APCs indicates the average annual change in
cancer incidence rate for each period segment. This model was used to
investigate CRC incidence trends by age group and separately for colon
and rectum. Thirdly, an age-period-cohort approach was used to en-
hance the understanding of disease trends by attempting to disentangle
factors that inﬂuence all ages (period eﬀects), such as changes in
medical practice, from those that vary by generation (cohort eﬀects),
typically because of behavioural changes. A R macro [19] was used to
ﬁt the age-period-cohort models following Osmond and Gardner
method [20], combining in a single general multiplicative risk model
the evaluation of the three dependent eﬀects.
Using data from the Italian National institute of Statistics (ISTAT),
we also examined changes in the age-structure of the municipality of
Milan between 2002 (ﬁrst available year with data) and 2015 (http://
demo.istat.it/). We constructed population pyramids for the two years.
3. Results
A total of 18,783 cases of CRC were reported to the Cancer Registry
of the municipality of Milan from 1999 to 2015, including 14,658
(78%) colon cancers. Of those 6628 (45%) were located in the right
(including transverse) colon (Table 1). The remaining 4125 individuals
(22%) presented with rectosigmoid or rectal cancers. Distributions of
demographic and tumour characteristics of the cohort, overall and by
tumor sub-site are reported in Table 1. Among people with colon
cancer, males were 50.8% while they were 54.4% amid those with
rectal cancer. Tumors of the rectum were more frequent compared to
colon cancer in adults younger than 50 years (3.6% vs. 4.6%). Ex-
cluding individuals with missing information, G3 tumors were 22.4% of
colon and 18.7% of rectal cancers, and Dukes-A stage neoplasia
amounted to 11.2% and 14.4%, respectively. Mucinous and signet ring
cell tumor (SRC) morphologies represented 9.0% of colon and 5.6% of
rectal cancers. Advanced stages (Dukes D) were more represented
among young CRC patients (25.0%) compared to those aged more than
65 years (18.8%). Mucinous and SRC morphologies were more frequent
in the youngest age group (12.0%) compared to oldest (8.3%).
Age-speciﬁc CRC incidence rates for each age group calculated by
year of birth (Fig. 1) showed a decreasing trend across birth cohorts
after age 44 years and stable rates up to 44 years, for both males and
females.
The analysis of age-speciﬁc annual incidence trends for all color-
ectal cancers (Fig. 2, ﬁrst row), showed a signiﬁcant decrease in the
50–60 age group for the entire period (APC, −3.0%; 95%CI, −4.1 to
−1.9). In the same age group, similar trends were documented for
colon (Fig. 2, central row; APC, −2.8%; 95%CI, −3.9 to −1.7) and
rectal cancers (Fig. 2, bottom row; APC−3.6: 95% CI−5.3; −1.8). In
people older than 60 years, a non-signiﬁcant uptrend up to 2006 (APC
1.0; 95%CI, −0.1–2.1) was followed by a consistent and signiﬁcant
decrease in annual incidence during the period 2007–2015 (APC,−4.2;
95%CI, −5.3 to −3.1). Separate analysis for colon and rectal sites
showed a similar uptrend, signiﬁcant for colon only (APC, 1.4; 95%CI,
0.4–2.3), followed by a downtrend starting in 2007. The decrease in
incidence was more pronounced for rectal (APC,−6.9; 95%CI,−9.1 to
−4.7) compared with colon cancer (APC,−3.4; 95%CI−4.3 to−2.5).
In patients aged less than 50 years (Fig. 2, ﬁrst column), the overall
CRC incidence rates increased from 1.9 to 2.1 per 100,000 (APC, 0.7%;
95%CI, −1.9 to 3.3) and for colon cancer from 1.2 to 1.8 per 100,000
(APC, 2.6%; 95% CI −0.9 to 6.2), albeit the annual change was not
statistically signiﬁcant. In contrast, rectal cancer showed a decreasing
trend from 0.9 to 0.4 per 100,000, not statistically signiﬁcant, also
among patients younger than 50 years (APC, -5.3%; 95%CI, -10.6 to
0.3).
Fig. 3 shows graphically the results of the age-period-cohort models
for colon cancer by gender. For the age eﬀect (panel A), the expected
increase of age speciﬁc rates with increasing age was documented. The
cohort eﬀect analysis (panel B) shows the incidence trend between
1925 and 1998, using the mean of the entire period as the reference
value. A reduction of cancer risk was detected for the cohorts born up to
1979, followed by an increase for the more recent cohorts. The risk
doubled for those born after 1987 compared to 1925, and continued to
rise up to the 1993 birth-cohort, having a sevenfold risk compared to
1979. Concerning period eﬀects (panel C), a moderate increase of
cancer risk from 1999 to 2015 was found. The trends for colon cancer
were similar in males and females. In contrast, the age-period-cohort
analysis of rectal cancer showed a modiﬁer eﬀect of gender (Fig. 4). In
men, trends are consistent with those seen in colon cancer, while
women showed an opposite pattern with a considerable risk reduction
in the most recent cohorts.
The changes in the age structure of the population of the munici-
pality of Milan over the study period were modest (Supplementary
Fig. 1). In 2002, the population aged 50 years or younger was 62.1% for
males and 53.3% for females, while in 2015 it was 63.2% and 55.5%,
respectively.
4. Discussion
The results of the study document, from 1999 to 2015, an increase
in the incidence of colorectal cancer in patients younger than 50 years
from 1.9 to 2.1 per 100,000, although the overall rates of CRC in the
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same period were declining. Previous reports in high-income non-
European countries documented a similar phenomenon [10–13].Parti-
cularly in the US, Bhandari et al., using SEER data, found that CRC is a
leading cause of cancer incidence and mortality among young adults in
the United States [21]. Additional analyses of US data showed an in-
crease of colorectal cancer incidence among young adults, due to an
increase in left-sided tumors, particularly in the rectum [8]. Cress et al.,
using all races combined SEER data from 1992 to 2001, documented an
increase of rectal cancer incidence in the population under 50 years, but
not for colon cancer [22]. Other authors reported an increase in in-
cidence rates among young adults aged 20–39 years, for both colon and
rectal cancers (SEER 1973–1999) [23]. This latter study however ex-
cluded cases 40–49 year olds, who represent 73% of CRC patients under
the age of ﬁfty.
The present study is population-based and used high-quality cancer
registry data collected over a 17-year period. In addition, multiple
statistical approaches were applied to understand the possible me-
chanisms involved in this trend changes: a more traditional graphical
approach, the joinpoint model estimating the APC- robust and largely
used – and, ﬁnally, the age-period-cohort models that disentangle the
age, cohort, and period eﬀects allowing to analyse them separately. A
birth cohort eﬀect can be induced by exposure to a risk or protective
factor acting on the early-stages of the carcinogenesis process (in-
itiators), with long latency periods. In contrast, a period eﬀect can be
attributed either to a risk or protective factor involved in the last stages
of the carcinogenesis process (promoters) and acting on all age groups,
or to changes in medical practice, including screening. SEER data [4]
suggest an impact of screening on decreased incidence and mortality for
CRC. Introduced in 2005, the organized screening of the Lombardy
region for CRC consisted, up to 2016, of a free fecal occult blood test
every two years, oﬀered through mail invitation to the population be-
tween 50 and 69 years. In the metropolitan area of Milan, adhesion to
screening has always been lower than 40% from 2005 to 2015. At the
regional level, women adhere more than men (51 vs. 44%) and 65–69
year-olds more than 50–54 year-olds (53% vs. 42%). The inﬂection
point evident at APC analysis in 2007 for the oldest age-group is co-
herent with screening introduction, as 2006–2007 can be considered
the ﬁrst round of the screening, with the recruitment of the prevalent
cases accumulated in the population, followed by the expected in-
cidence reduction from 2008. However, the trends documented in this
study cannot be attributed entirely to the introduction of screening, also
because no decreasing period eﬀect was found in the age-period-cohort
model. The evidence of a decreasing birth cohort eﬀect for those born
up to 1979 suggests that the overall decrease can be largely attributed
to risk factors modiﬁcation or/and to the healthier lifestyles. This trend
reversed for those born in the eighties or after. The observed increasing
incidence of CRC among patients younger than 50 years of age in dif-
ferent high-income countries has been attributed to behavioural factors:
obesity, physical inactivity and diet are all risk factors associated with
an increased risk for CRC [24,25]. These are potentially modiﬁable
factors with a favourable cost-beneﬁt balance for the health care system
and may inﬂuence reducing the health eﬀects for many cancer sites and
cardiovascular diseases. In Italy, data from surveys representative of the
general adult population indicated - from 1983 to 2008 - an increase of
overweight of 10.5% in males and of 4.2% in females and of obesity of
3.6% in males and of 1.4% in females (0.056% per year). Obesity, that
represents a surrogate of multiple risk factor exposure (high-risk diet
proﬁle, hyperglycemia and low physical activity), is more evident in
males than in females and more evident in the population younger than
50 years [26].
Comparing the ﬁndings of this study with the previous reports in the
non-European countries [10–13], the main diﬀerence is that an oppo-
site trend between colon and rectal cancer was found in Milan in people
younger than 50 years and in the female population, with rectal cancer
declining in a similar way as in older patients. Particularly, in females
rectal cancer had decreasing trends in both birth cohort and period
Table 1
Distribution of main characteristics of colorectal cancers cases. (Cancer Registry of Milan 1999–2015, Italy).
Site of the Primary Tumor Age Groups (years) Total CRC cases
Colon Rectum <50 50-64 65+
Years Incidence
1999–2003 4349 (29.67%) 1397 (33.87%) 216 (30.04%) 1250 (35.03%) 4280 (29.53%) 5746
2004–2007 3707 (25.29%) 1115 (27.03%) 161 (22.39%) 926 (25.95%) 3735 (25.77%) 4822
2008–2011 3524 (24.04%) 888 (21.53%) 182 (25.31%) 764 (21.41%) 3466 (23.91%) 4412
2012–2015 3078 (21.00%) 725 (17.58%) 160 (22.25%) 628 (17.60%) 3015 (20.80%) 3803
Age groups (years)
<50 530 (3.62%) 189 (4.58%) – – – 719
50–64 2584 (17.63%) 984 (23.85%) – – – 3568
65+ 11,544 (78.76%) 2952 (71.56%) – – – 14,496
Gender
Males 7440 (50.76%) 2243 (54.38%) 363 (50.49%) 1971 (55.24%) 7349 (50.70%) 9683
Females 7218 (49.24%) 1882 (45.62%) 356 (49.51%) 1597 (44.76%) 7147 (49.30%) 9100
Grading
G1 897 (6.12%) 273 (6.62%) 52 (7.23%) 245 (6.87%) 873 (6.02%) 1170
G2 7742 (52.82%) 2138 (51.83%) 338 (47.01%) 2004 (56.17%) 7538 (52.00%) 9880
G3 2496 (17.03%) 554 (13.43%) 124 (17.25%) 569 (15.95%) 2357 (16.26%) 3050
missing 3523 (24.03%) 1160 (28.12%) 205 (28.51%) 750 (21.02%) 3728 (25.72%) 4683
DUKES staging
A 1331 (9.08%) 440 (10.67%) 56 (7.79%) 424 (11.88%) 1291 (8.91%) 1771
B 2632 (17.96%) 633 (15.35%) 102 (14.19%) 565 (15.84%) 2598 (17.92%) 3265
C 5690 (38.82%) 1411 (34.21%) 278 (38.66%) 1476 (41.37%) 5347 (36.89%) 7101
D 2232 (15.23%) 571 (13.84%) 145 (20.17%) 512 (14.35%) 2146 (14.80%) 2803
missing 2773 (18.92%) 1070 (25.94%) 138 (19.19%) 591 (16.56%) 3114 (21.48%) 3843
Mucinousa
No 13,339 (91.00%) 3894 (94.40%) 633 (88.04%) 3311 (92.80%) 13,289 (91.67%) 17,233
Yes 1319 (9.00%) 231 (5.60%) 86 (11.96%) 257 (7.20%) 1207 (8.33%) 1550
Total 14,658 4125 719 3568 14,496 18,783
a Mucinous and signet ring cell tumors.
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analyses, while in males there was a growing trend by period and for
cohorts born from the end of ‘70 onwards. Although based on a limited
number of cases, this ﬁnding would require additional investigations to
deﬁne which risk and/or protective factors are involved, including the
life-style changes mentioned above [26] that have a diﬀerent pre-
valence between sexes. One of the additional aspects to study is re-
presented by the access of the female population to at least one gy-
naecological examination each year between 30 and 50 years, which
could induce a rectosigmoidoscopy with removal of the preneoplastic
lesions in case of bleeding adenomas. Also, the ﬁnding of diﬀerent
trends in colon and rectal cancer incidence between Milan, located in
southern Europe, and US suggest that the underlying causes inducing
CRC in young individuals might be several and diﬀerently represented
in diﬀerent regions, even within high income countries.
Early-onset CRC is a hallmark of inherited cancer predisposition and
approximately 15–30% of cases are expected to have a signiﬁcant fa-
milial history and/or genetic predisposition [27]. In this study, early-
onset CRC were more likely to be diagnosed at advanced stages (III and
IV) and more frequently mucinous or signet-ring cancers, if compared
to the overall population, in agreement with previous publications
[28–31].
For subjects without a familial history and/or known genetic pre-
disposition, CRC screening in Italy has been extended to the 50–74 year
old population from 2016. In this age group, the incidence and mor-
tality reduction for screening attenders have been documented [3–5].
The opposite trend observed among adults younger than 50 years may
be partly due to the lack of indication to screening with FOBT in this
age group [3–5]. Recently, a study reporting results of the ﬁrst attempt
to extend screening to lower ages has been published, but deﬁnitive
data supporting this topic are still far from being presented [32].
5. Conclusion
The available evidences about the increase in the incidence of col-
orectal cancer among young adults compared to the decrease for the
population over the age of 50 pose the problem to identify and reduce
modiﬁable risk factors and improving healthy lifestyles in this age
group. Also, the eﬀectiveness of extending screening to younger ages
should be evaluated.
Fig. 1. Age-speciﬁc colorectal cancer incidence rates per 100,000 from 1999 to 2015 by cohort (year of birth) and gender. (Cancer Registry of the Municipality of
Milan, Italy).
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Fig. 2. Trends in age-speciﬁc (age groups, < 50, 50–60 and 60+ years) annual incidence rates per 100,000 for colorectal (upper panels), colon (middle panels), and
rectal (lower panels) cancers (Cancer Registry of the Municipality of Milan, Italy, 1999–2015).
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